Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanotransduction-Mediated Expansion of Rabbit Vocal Fold Epithelial Cells via ROCK Inhibition and Stromal Cell-Derived Paracrine Signals. | Cells | 2025 | 41002379 | PubTator, text mining | PubMed |
| Bending the boundaries: the many facets of endophilin-As from membrane dynamics to disease. | Cell Mol Life Sci | 2025 | 40986063 | PubTator, text mining | PubMed |
| The Expanding Genetic Architecture of Arteriopathies: From Canonical TAAD Genes to Emerging Connective Tissue and Signaling Pathways. | Med Sci (Basel) | 2025 | 40981152 | PubTator, text mining | PubMed |
| Caveolae and Rho Kinase: their implication of the senescent cell morphology and the secretion of the SASP in HeLa and A549 cancer cells. | Med Oncol | 2025 | 40960571 | PubTator, text mining | PubMed |
| Prostaglandin E2 inhibits adipogenesis through the cilia-dependent activation of ROCK2. | J Cell Sci | 2025 | 40955174 | PubTator, text mining | PubMed |
| ROCK 2 inhibition with belumosudil for the treatment of chronic graft-versus-host disease: a narrative review. | Ther Adv Hematol | 2025 | 40951719 | PubTator, text mining | PubMed |
| Erratum: Activation of RhoA/ROCK2 signaling by hypoxia-inducible factor 1α in promoting tumor growth and metastasis in human colon cancer. | J Gastrointest Oncol | 2025 | 40950332 | PubTator, text mining | PubMed |
| Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma. | Sci Adv | 2025 | 40901948 | PubTator, text mining | PubMed |
| Discovery of A20 with 4-(2-methoxyphenyl)-1H-pyrazole scaffold as a potent and selective ROCK2 inhibitor. | Bioorg Med Chem Lett | 2025 | 40886899 | PubTator, text mining | PubMed |
| APEX1-STAT3 signaling mediates the force-coordinated endothelial regeneration. | Cell Mol Life Sci | 2025 | 40879745 | PubTator, text mining | PubMed |
| Targeting ROCK2 to Restore Epileptic Synaptic Networks via Mitophagy Activation: Insights from Translational Imaging of SV2A In Vivo. | Adv Sci (Weinh) | 2025 | 40878444 | PubTator, text mining | PubMed |
| When Functional Assessment Meets Intravascular Imaging in Patients with Coronary Artery Disease. | J Cardiovasc Dev Dis | 2025 | 40863385 | PubTator, text mining | PubMed |
| The Dark Side of Vascular Aging: Noncoding Ribonucleic Acids in Heart Failure with Preserved Ejection Fraction. | Cells | 2025 | 40862748 | PubTator, text mining | PubMed |
| A bibliometric analysis of trends and hotspots in autophagy in gastric cancer. | Discov Oncol | 2025 | 40859059 | PubTator, text mining | PubMed |
| Rho kinase isoforms in neurodegeneration: from cellular functions to therapeutic targets. | Mol Biol Rep | 2025 | 40856865 | PubTator, text mining | PubMed |
| Revealing the biophysics of lamina-associated domain formation by integrating theoretical modeling and high-resolution imaging. | Nat Commun | 2025 | 40854894 | PubTator, text mining | PubMed |
| Corrigendum to "Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury" [Eur. J. Pharmacol. 1004 (2025) 178009]. | Eur J Pharmacol | 2025 | 40854787 | PubTator, text mining | PubMed |
| Novel Pretreatment Autoantibodies Correlate with Enfortumab Vedotin-Related Dermatologic Events in Patients with Advanced Urothelial Cancer. | Cancer Res Commun | 2025 | 40828987 | PubTator, text mining | PubMed |
| Retraction: MiRNA-200b regulates RMP7-induced increases in blood-tumor barrier permeability by targeting RhoA and ROCKII. | Front Mol Neurosci | 2025 | 40822325 | PubTator, text mining | PubMed |
| Design and synthesis of ROCK2-selective inhibitors bearing 6-indazolamino-2-pyrrolidinylpyridine for the treatment of breast cancer metastasis. | Bioorg Chem | 2025 | 40811902 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=7